# Alterations in Cognitive Function and Cerebral Blood Flow After Conversion From Immediate Release Tacrolimus to Slow Release Envarsus

> **NCT03703154** · — · COMPLETED · sponsor: **University of Kansas Medical Center** · enrollment: 30 (actual)

## Conditions studied

- End Stage Renal Disease

## Interventions

- **DRUG:** Envarsus
- **DRUG:** Tacrolimus

## Key facts

- **NCT ID:** NCT03703154
- **Lead sponsor:** University of Kansas Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-25
- **Primary completion:** 2021-03-03
- **Final completion:** 2021-03-03
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2021-04-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03703154

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03703154, "Alterations in Cognitive Function and Cerebral Blood Flow After Conversion From Immediate Release Tacrolimus to Slow Release Envarsus". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03703154. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*